Inventor
YI FONG LIN
Inventor
TW
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes50%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations50%
PatentTitleYear
12,551,437Liposome compositions comprising weak acid drugs and uses thereof202612,220,483Liposome compositions comprising weak acid drugs and uses thereof202512,064,406Pharmaceutical composition of a weak acid drug and methods of administration202411,964,050Liposome compositions comprising weak acid drugs and uses thereof202411,833,125Pharmaceutical composition for controlled release of treprostinil202311,229,616Pharmaceutical composition for controlled release of treprostinil2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to PHARMOSA BIOPHARM INC (6)· patent assignee history
2022Patents assigned to PHARMOSA THERAPEUTICS INC (1)· patent assignee history
2022–2026Based in TW· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PHARMOSA BIOPHARM INC | 6 | 2022–2026 |
| PHARMOSA THERAPEUTICS INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| TW | 6 | 2022–2026 |